Perfil
Ashutosh Tyagi formerly worked at Y-mAbs Therapeutics, Inc., as Independent Director from 2017 to 2025, Scopia Capital Management LP, as Partner from 2010 to 2018, Citigroup Global Markets, Inc., as Associate in 2004, and Morgan Stanley & Co. LLC, as Portfolio Manager.
Dr. Tyagi received his undergraduate degree from the University of Michigan, Masters Business Admin degree from Stephen M.
Ross School of Business, and doctorate degree from the University of Michigan Medical School.
Antiguos cargos conocidos de Ashutosh Tyagi.
| Empresas | Cargo | Fin |
|---|---|---|
| YMAS THER | Director/Miembro de la Junta | 16/09/2025 |
Scopia Capital Management LP
Scopia Capital Management LP Investment ManagersFinance Scopia employs a fundamentals-based, value-driven investment approach across two strategies: a long-short equity strategy managed with the discipline of market neutrality and a long-only equity strategy. The firm seeks to identify investments primarily in publicly-traded equities (on both US and non-US exchanges), including IPOs, and conversely to identify and sell short stocks that they believe will drop in value (or at least under-perform) regardless of the industry and the market’s overall direction. | Gestor de Cartera-Acciones | 01/01/2018 |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 30/09/2008 |
Citigroup Global Markets, Inc.
Citigroup Global Markets, Inc. Investment Banks/BrokersFinance Provides investment banking, financial and wealth management services | Corporate Officer/Principal | 30/03/2004 |
Formación de Ashutosh Tyagi.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Scopia Capital Management LP
Scopia Capital Management LP Investment ManagersFinance Scopia employs a fundamentals-based, value-driven investment approach across two strategies: a long-short equity strategy managed with the discipline of market neutrality and a long-only equity strategy. The firm seeks to identify investments primarily in publicly-traded equities (on both US and non-US exchanges), including IPOs, and conversely to identify and sell short stocks that they believe will drop in value (or at least under-perform) regardless of the industry and the market’s overall direction. | Finance |
Citigroup Global Markets, Inc.
Citigroup Global Markets, Inc. Investment Banks/BrokersFinance Provides investment banking, financial and wealth management services | Finance |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan Medical School
University of Michigan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
- Bolsa de valores
- Insiders
- Ashutosh Tyagi
















